Johnson & Johnson Talc Asbestos Concealment: What the Toxicologist Found, What the Company Hid, and What It Means for Your Family
If you are reading this page, you or someone you love has likely been diagnosed with mesothelioma or ovarian cancer after years of using talcum powder — and you are trying to understand whether the powder on your bathroom shelf for decades could be the reason. We are going to tell you what just happened in a courtroom, what it means for your situation, and what you should do next. We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic tort and product liability cases, and we built this page because the testimony that just came out of an active trial changes what is known about what Johnson & Johnson knew, when it knew it, and what it chose to do with that knowledge.
Here is what happened, in plain language. A jury in an ongoing trial — where three women blame Johnson & Johnson’s talc products for their ovarian cancer — watched a videotaped deposition of a former J&J toxicologist named John Hopkins. Years ago, Hopkins prepared a report for J&J in which he wrote that he had “unmistakably” found chrysotile asbestos in the company’s talc. He included photographs of the fibers. He wrote that the “needle-like structure of asbestos” is what gives it “the ability to embed in pulmonary tissue and potentially lead to mesothelioma.” And when he was asked, under oath, whether he had ever seen evidence that his findings were provided to the U.S. Food and Drug Administration — he said no.
That single answer sits at the center of both the ovarian cancer litigation and the mesothelioma litigation against this company. It contradicts what J&J told the FDA. It contradicts what J&J told the public. And it connects a corporate decision to conceal asbestos findings to the diseases that follow decades later.
What the Toxicologist Found — and What J&J Did With It
The Hopkins Report: Asbestos Found, Photographed, and Then What?
John Hopkins was not an outside critic. He was Johnson & Johnson’s own toxicologist. He prepared a report for the company saying he had found chrysotile asbestos — the most common form of asbestos, and a recognized cause of mesothelioma — in J&J’s talc. He documented the finding with photographs of the fibers. And he wrote, in that same report, about the specific physical property that makes asbestos dangerous:
“the needle-like structure of asbestos … is the quality that gives it the ability to embed in pulmonary tissue and potentially lead to mesothelioma.”
This was not a tentative finding. The word he used was “unmistakably.” And in his deposition, he acknowledged that this written warning existed — even though he had previously denied that company documents demonstrated knowledge of mesothelioma-causing asbestos in its talc.
The question every person reading this page should ask is simple: if your own scientist found asbestos in your product and told you it could cause mesothelioma, what did you do with that information? And the answer emerging from this trial is: the company appears not to have given it to the FDA.
The Internal Documents: “Control” and “Compromise”
The jury saw more than Hopkins’s report. They saw internal corporate documents — memos from J&J executives — that describe a deliberate strategy to shape the scientific record around talc and asbestos.
One internal document quoted an executive writing:
“I think it’s important that we originate this study and therefore control the work.”
When confronted with memos in which executives discussed the need to “compromise” research linking talc to asbestos, Hopkins insisted the word only meant to “challenge” it. But a jury does not have to accept that characterization. A jury can read the word “compromise” in the context of a company that had its own scientist’s photographs of asbestos fibers and chose not to forward them to the federal regulator responsible for monitoring cosmetic safety.
Another document shown to the jury revealed that J&J told the FDA that a “substantial” amount of asbestos would be safe to allow in its talc products. Hopkins tried to characterize this as merely responding to an FDA request rather than advocating for permissible levels of a mesothelioma-causing substance. Again, a jury can decide for itself whether a company that internally knew its talc contained asbestos was being forthcoming when it told the regulator that a “substantial” amount was acceptable.
Did Johnson & Johnson Tell the FDA About the Asbestos in Its Talc?
The FDA Disclosure Gap
This is the heart of the concealment case. Johnson & Johnson represented to the FDA that it had turned over all relevant documents and tests about the presence of asbestos in its products. The Hopkins testimony directly contradicts that representation. Hopkins — the man who prepared the report finding chrysotile asbestos, who included photographs of the fibers — said under oath that he had never seen evidence his research was provided to the FDA.
Here is why that matters beyond a single trial. The FDA regulates cosmetic products under the Federal Food, Drug, and Cosmetic Act, but its authority over cosmetics is substantially narrower than its authority over drugs or medical devices. Cosmetics do not require premarket FDA approval. The FDA’s mandatory recall authority is limited. And critically, the FDA does not independently require testing for asbestos contamination in cosmetic talc — it relies on manufacturer self-reporting and voluntary industry standards.
That regulatory framework only works if manufacturers tell the truth. When a company possesses internal documentation of asbestos in its talc — photographs of the fibers, a written warning from its own toxicologist about mesothelioma risk — and that documentation never reaches the FDA, the entire system of manufacturer candor breaks down. The regulator cannot regulate what it is never told. And the consumer cannot make an informed choice about a product whose risks were documented internally and withheld externally.
What the FDA Has Found on Its Own
The FDA has conducted surveys of cosmetic talc products and found asbestos in certain samples. This is consistent with the internal findings described in the Hopkins testimony. The fact that the FDA’s own independent surveys turned up asbestos — even without the benefit of J&J’s internal reports — underscores that the contamination was real, not theoretical, and that the company’s failure to disclose its own confirmatory findings deprived the regulator of information it needed and was entitled to.
Who Can Be Held Responsible: The Johnson & Johnson Corporate Structure
The Entity Stack — and Why It Matters to Your Case
Johnson & Johnson is not a single company. It is a corporate family, and understanding that family is essential to understanding who is liable, who has the assets to pay, and what procedural obstacles exist.
The parent corporation is Johnson & Johnson. The operating subsidiary that designed, tested, marketed, and sold the consumer talc products at issue is J&J Consumer Inc. (JJCI) — the historical talc seller. Beyond that, the talc liability has been shuffled through a series of entities that are not accidents of corporate bookkeeping; they are deliberate structural maneuvers:
- LTL Management LLC — the entity created through a “Texas two-step” divisional merger to hold talc liability. It filed for Chapter 11 bankruptcy twice. Both filings were dismissed.
- Red River Talc LLC — the renamed successor liability vehicle used for a third bankruptcy attempt. On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas denied confirmation and dismissed this filing as well — J&J’s third failed bankruptcy bid.
- Kenvue Inc. — the consumer-health spinoff (the company behind Band-Aid, Tylenol, Listerine). J&J has indemnity arrangements with Kenvue, but Kenvue is now a separate publicly traded company.
After three failed bankruptcy attempts, Johnson & Johnson announced a return to defending cases in the regular tort system. What this means for you: the bankruptcy strategy that was designed to wall off these cases and force claimants into a capped settlement fund has failed. The cases are back in the courts. And the courts are where concealment evidence like the Hopkins testimony does its most devastating work.
The Talc Supplier: Imerys Talc America
Johnson & Johnson was not the only entity in the chain. Imerys Talc America / Imerys Talc Vermont supplied raw talc to J&J. Imerys faced its own talc litigation liability and filed for Chapter 11 bankruptcy. There may be chain-of-distribution and negligence liability for supplying asbestos-contaminated raw material. Depending on the specifics of your exposure history and the jurisdiction where your claim would be filed, the talc supplier may be an additional defendant or a source of recovery through a bankruptcy trust.
Other Potential Defendants
In jurisdictions that recognize seller liability for defective products, retail and distribution chain entities may also be named under a strict product liability chain-of-distribution theory. These downstream sellers typically seek indemnification from the manufacturer, but in some states they remain in the case and can contribute to the recovery architecture.
The Diseases: Mesothelioma and Ovarian Cancer From Talc
Mesothelioma — The Signature Asbestos Disease
Mesothelioma is a cancer of the lining of the lungs (the pleura) and, less commonly, the abdomen (the peritoneum). It is essentially specific to asbestos exposure. The world’s leading cancer authority — the International Agency for Research on Cancer — classifies all forms of asbestos as a Group 1 carcinogen, its highest category: known to cause cancer in humans. There is no live scientific debate about whether asbestos causes mesothelioma. The disease itself is near-conclusive proof of asbestos exposure.
The mechanism is physical and brutal. Inhaled asbestos fibers — especially the needle-like chrysotile fibers that Hopkins photographed in J&J’s talc — are too durable for the body to break down or clear. They lodge in the pleura. Over decades, the chronic physical irritation and the chemical damage to the cells lining the lung produce malignant transformation. The fiber’s near-indestructibility is why a single exposure window, even decades earlier, can seed the disease.
The latency is extraordinary. Mesothelioma typically appears 20 to 50 years after first asbestos exposure — most commonly 30 to 40 years. A woman who used talcum powder daily in her twenties may not be diagnosed until her sixties or seventies. That decades-long delay is not a coincidence or a weakness in the case — it is the medical signature of the disease. And it is exactly why the law in most states does not start the statute-of-limitations clock at the time of exposure. It starts it at the time of diagnosis, when the connection between the disease and its cause can finally be made.
Mesothelioma’s prognosis is devastating. Median survival from diagnosis is approximately 12 to 21 months. Treatment may include surgery (pleurectomy/decortication or extrapleural pneumonectomy), chemotherapy, radiation, immunotherapy, and palliative care. The medical costs alone frequently exceed several hundred thousand dollars. And because the disease is almost universally fatal, wrongful death and survival claims are central to the damages architecture.
Ovarian Cancer — The Perineal Talc Exposure Pathway
The trial where Hopkins testified involves three women with ovarian cancer. The causal theory is that talc particles applied to the perineal area — the genital region — can migrate through the reproductive tract to the ovaries, where chronic inflammation and the presence of asbestos-contaminated fibers may contribute to malignant transformation. The relationship between perineal talc use and ovarian cancer has been the subject of substantial epidemiological study and litigation, and juries have returned significant verdicts for plaintiffs on this theory.
Ovarian cancer carries its own devastating prognosis and treatment burden — surgical intervention, chemotherapy, and, in advanced or recurrent cases, ongoing maintenance therapy. The medical costs, lost earnings, and human suffering are substantial, and the concealment evidence described in the Hopkins testimony applies with equal force to the ovarian cancer cases: if the company knew its talc contained asbestos and did not disclose that to the FDA or warn consumers, the failure to warn is the same regardless of which disease followed.
The Regulatory Failure: Why FDA Authority Over Cosmetics Is Dangerously Narrow
The Framework That Depends on Manufacturer Honesty
The FDA regulates cosmetic products under the Federal Food, Drug, and Cosmetic Act. But the agency’s authority over cosmetics is fundamentally different from its authority over drugs and medical devices:
- No premarket approval. Cosmetic products do not require FDA approval before they go on the market. A company can formulate, test, manufacture, and ship a cosmetic product without the FDA ever reviewing it.
- Limited recall authority. The FDA’s ability to force a mandatory recall of cosmetics is limited. The agency largely relies on voluntary company action.
- No independent asbestos testing requirement. Talc used in cosmetics is subject to FDA monitoring, but the agency does not independently require manufacturers to test for asbestos contamination. The system relies on manufacturer self-reporting and voluntary industry standards.
This framework creates a structural vulnerability: the entire regulatory regime depends on manufacturers being candid with the FDA. When a manufacturer withholds internal findings of asbestos contamination — as the Hopkins testimony suggests J&J did — the regulator is deprived of the information it needs to act, and consumers are deprived of the information they need to make safe choices.
Why the Hopkins Testimony Is So Damaging
The Hopkins deposition is not just one man’s recollection. It is evidence of a gap between what a company knew internally and what it represented externally. J&J told the FDA it had turned over all relevant asbestos testing documents. Hopkins — the author of a report that “unmistakably” found chrysotile asbestos in the company’s talc, complete with photographs — said he had never seen evidence his findings were provided to the FDA. That gap is the factual core of a fraudulent concealment theory and a negligent misrepresentation theory. It is also the kind of evidence that moves a case from ordinary product liability into the territory of punitive damages.
The Evidence You Need to Preserve — and How Fast It Disappears
The Records That Decide a Talc Case
A talc litigation case is built from several layers of evidence. Some of it is already in the public litigation record from prior trials. Some of it is yours to preserve, and the clock on your evidence may already be running.
Internal J&J documents. The corporate documents referencing asbestos findings, talc testing, and FDA communications are the spine of the liability case. These have largely been produced through existing litigation discovery, but they require authentication and chain-of-custody verification for individual cases. The Hopkins deposition transcripts are preserved in court records. The underlying reports and photographs should be secured through subpoena if not already in the litigation record.
Your medical records. Your oncology records establishing your cancer diagnosis, treatment history, and temporal timeline are required for specific causation, damages quantification, and survival or wrongful death claims. Medical records must be obtained before treatment facilities archive or destroy them under their own record-retention schedules. Hospitals and clinics do not keep records forever — many purge adult records after a set number of years. Your complete treatment record, from the first imaging that flagged the tumor through every surgery and infusion, is the medical spine of your case.
Product use history. This is the evidence that links you specifically to J&J talc products. Receipts, purchase records, pharmacy or store loyalty-card data, photographs of product containers, and — critically — the recollections of family members who can describe your use patterns over years or decades. Product containers and receipts degrade or are discarded over time. Family member memories fade. These recollections should be recorded immediately while they are fresh and detailed.
FDA correspondence. The gap between J&J’s internal knowledge and its regulatory disclosures is documented in part through FDA correspondence and submissions. These federal records are preserved, but obtaining a complete production requires Freedom of Information Act requests or litigation discovery that should be initiated promptly.
Preserved product samples. If you still have talc product containers from the years you were using them, the product itself can be mineralogically tested to confirm the presence and type of asbestos fibers in the specific lots you used. Product samples must be preserved and tested before degradation, and the analytical methods must meet jurisdictional evidentiary standards. A container of Johnson’s Baby Powder or Shower to Shower from the 1980s or 1990s is not a household artifact — it is potential evidence.
The Clock That Should Worry You
Here is the urgency, stated plainly. Mesothelioma patients face a limited life expectancy. Your live testimony regarding product use history — which brand you used, how often, for how many years, where you applied it — may be irreplaceable evidence at trial. If you are too ill to testify, or if you pass away before your deposition is taken, the case does not end, but the strongest evidence of your personal exposure pathway may be diminished. Family members who observed your use patterns should be identified and their recollections documented while those memories are intact.
Medical records, product containers, and witness recollections are not things that improve with time. Every month that passes before a preservation letter goes out and a records demand is filed is a month in which evidence can be lost, destroyed, or degraded. The day you call a lawyer is the day the clock starts working for you instead of against you.
What a Talc Case Is Worth
The Value Range
We are not going to promise you a number. No honest lawyer can look at a website and tell you what your case is worth without knowing your diagnosis, your treatment history, your product use documentation, your jurisdiction, and the current state of the litigation landscape. What we can tell you is the range that has emerged from the litigation to date, honestly framed.
Individual talc case values in the Johnson & Johnson litigation have ranged from approximately $2 million on the low end to $50 million or more on the high end per individual plaintiff. The factors that drive where a case falls in that range include:
- Diagnosis type. Mesothelioma cases generally command higher values than ovarian cancer cases because mesothelioma’s near-universal fatality and its more established asbestos causation pathway make the damages and the liability clearer.
- Product use documentation. A plaintiff who can produce receipts, photographs of product containers, and detailed family testimony about decades of daily talc use has a stronger specific-causation case than one whose use history is less documented.
- Jurisdiction and venue. Where the case is filed matters. Different states have different damage caps, different punitive-damages standards, and different jury pools.
- Concealment evidence. The Hopkins testimony and the internal executive memos about “compromising” and “controlling” research are exactly the kind of evidence that amplifies punitive damage exposure. When a jury learns that a company’s own scientist found asbestos and the findings were not given to the FDA, the punitive component of a verdict can be substantial.
The Headline Verdict — and What Actually Happened to It
In 2018, a Missouri jury returned a verdict of $4.69 billion against Johnson & Johnson in a case involving 22 women who claimed talc caused their ovarian cancer. That number made headlines. But the number that matters is what happened next.
The Missouri Court of Appeals reduced the verdict to approximately $2.12 billion. The Missouri Supreme Court declined to review the reduction. And on June 1, 2021, the United States Supreme Court denied certiorari — meaning the reduced $2.12 billion award stands as final.
That is the cite-safe number: approximately $2.12 billion, affirmed through the highest court in the country’s refusal to disturb it. We tell you this not to promise you a similar outcome — past results depend on the facts of each case and do not guarantee future outcomes — but to show you that these cases can produce verdicts that survive appeal, and that the concealment evidence matters to juries.
Collectibility
Johnson & Johnson is one of the largest corporations in the world. Its assets are substantial. Collectibility — the question of whether a verdict can actually be paid — is not the concern here that it would be with a smaller defendant. However, the subsidiary bankruptcy attempts and the proposed global settlement structures create procedural uncertainty that may affect how individual recoveries are structured. The bankruptcy strategy has failed three times, but the company’s approach to resolving the aggregate litigation continues to evolve.
The Defense Playbook: What Johnson & Johnson’s Lawyers Will Try
Play 1: “Talc Does Not Contain Asbestos”
The company has historically maintained that its talc products do not contain asbestos. The Hopkins testimony — from J&J’s own toxicologist, with photographs — directly contradicts this position. The defense may attempt to distinguish between different testing methodologies, different product lots, or different time periods. The counter is the documentary record: a J&J scientist found chrysotile asbestos, photographed it, and wrote about its mesothelioma-causing properties. That is not an outside critic’s opinion. It is the company’s own finding.
Play 2: “Your Cancer Came From Something Else”
For mesothelioma cases, this play is weak — mesothelioma is so specific to asbestos that the disease itself is near-conclusive proof of exposure. But the defense may argue that your asbestos exposure came from another source: a different job, a different product, a family member’s work clothes. The counter is your product use history. If you used J&J talc products daily for decades, and you have no other known asbestos exposure pathway, the talc connection is the most plausible cause. For ovarian cancer cases, the defense may argue that ovarian cancer has many causes and that talc use is not the specific cause of your cancer. The counter is the epidemiological evidence linking perineal talc use to elevated ovarian cancer risk, combined with the concealment evidence showing the company knew of the asbestos contamination.
Play 3: “We Told the FDA Everything”
J&J has represented to the FDA that it disclosed all relevant asbestos testing. The Hopkins testimony contradicts this directly. The defense may attempt to characterize the gap as an administrative oversight or a difference in interpretation about what was “relevant.” The counter is the document itself: a report that “unmistakably” found chrysotile asbestos, with photographs, written by the company’s own toxicologist, with a written explanation of the mesothelioma mechanism. A jury can decide whether failing to forward that report to the FDA was an “oversight” or a choice.
Play 4: The Statute of Limitations Defense
The defense will argue that too much time has passed between your talc use and your lawsuit. This is where the discovery rule — the legal doctrine that starts the clock at diagnosis, not at exposure — is your answer. Most states apply this rule for toxic exposure and latent-disease claims. But the specific formulation, the length of the limitations period, and whether your state has a statute of repose that creates an outer deadline are all jurisdiction-specific questions that must be confirmed for your state immediately. Do not assume you have “plenty of time” — and do not assume you are “too late.” The only way to know is to have a lawyer confirm the deadline that applies to you.
Play 5: Bankruptcy and Global Settlement Pressure
J&J has used the bankruptcy system three times to try to wall off these claims. Each attempt has failed, but the company continues to pursue settlement structures that could affect how individual claims are resolved. The defense may argue that your claim should be channeled into a settlement program rather than tried individually. The counter is that three courts have rejected the bankruptcy strategy, and your right to a jury trial in the tort system remains intact. But the procedural landscape is shifting, and acting before it shifts further is part of protecting your rights.
How a Talc Case Is Actually Built
Week One: The Preservation Letter and Records Demand
The first thing that happens when you call is not a lawsuit. It is a preservation letter — a formal demand directed to Johnson & Johnson and any other relevant parties to freeze every document, every internal communication, every testing record, and every FDA submission related to asbestos in talc. This letter creates a legal obligation. If documents are destroyed after the letter is received, the destruction becomes a spoliation issue that can trigger adverse-inference instructions and sanctions.
Simultaneously, a records demand goes out for your complete medical file — every imaging study, every pathology report, every treatment note, every billing record. Your oncology records establish the diagnosis, the treatment timeline, and the damages architecture.
Weeks Two Through Four: Product Use Reconstruction
Your product use history is the bridge between the corporate concealment evidence and your specific injury. We work with you to build a detailed timeline: which talc products you used (Johnson’s Baby Powder, Shower to Shower, other J&J brands), how frequently you used them, over what span of years, and where on your body you applied them. Family members, former partners, and longtime friends may be asked to provide corroborating recollections. Any surviving product containers, receipts, or photographs are identified and secured.
The Expert Phase: Causation and Damages
A talc case requires expert witnesses at multiple levels:
- Board-certified oncologists and epidemiologists establish general causation — the scientific link between asbestos-contaminated talc and your specific disease (mesothelioma or ovarian cancer).
- Mineralogists and analytical chemists confirm the presence and type of asbestos fibers in product samples, using methods that meet evidentiary standards.
- Regulatory compliance experts frame the FDA disclosure failures — explaining what the company was required to report, what it actually reported, and what the gap means.
- Life-care planners and forensic economists build the damages number — projecting the lifetime cost of medical care, lost earning capacity, and the human losses no receipt can capture.
The Hopkins Deposition and the Internal Documents
The Hopkins deposition and the executive memos discussing “compromising” and “controlling” research are exhibit-centerpiece material. They are not our opinion about what J&J did. They are the company’s own words, captured under oath and in internal communications, showing knowledge of asbestos contamination and a strategy to manage the scientific record. In both the liability phase and the punitive damages phase, these documents are where the case turns from “a company made a product that turned out to be dangerous” to “a company knew its product was dangerous and chose not to tell the regulator or the public.”
Discovery, Depositions, and the Trial Calendar
The consolidated multidistrict litigation — MDL-2738, In re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, pending in the District of New Jersey — had over 68,000 actions pending as of mid-2026. Individual cases within the MDL proceed on their own timelines. Discovery in individual cases leverages the extensive document production from prior J&J talc trials while pursuing case-specific evidence. Mediation and global settlement dynamics are influenced by J&J’s aggregate exposure across thousands of pending cases and the reputational cost of continued public trials revealing concealment evidence like the Hopkins testimony.
Your First Steps: What to Do Now
1. Preserve Everything
If you have any remaining talc product containers — old bottles of Johnson’s Baby Powder, Shower to Shower, or any J&J talc product — do not throw them away. Photograph them from every angle, including any lot numbers or date codes. Store them in a clean, dry place. These containers are potential evidence that can be mineralogically tested.
Gather any receipts, loyalty-card purchase histories, or old photographs that show talc products in your home. Write down everything you remember about your talc use: which brands, how often, what years, where you applied the product. Do this now, while the memories are as detailed as they will ever be.
2. Get Your Complete Medical Records
Request your complete oncology file from every treating facility — not just the summary, but the full record including imaging, pathology reports, treatment notes, and billing records. Hospitals operate on record-retention schedules, and records can become harder to obtain over time. Your medical records are the proof of your diagnosis, your treatment, and your damages.
3. Talk to Family Members
Ask your spouse, adult children, siblings, or longtime friends what they remember about your talc use. Their recollections — “she used Johnson’s Baby Powder every morning after her shower for as long as I can remember” — are evidence. Record these conversations in writing. Identify who could testify to your use patterns if your own testimony becomes unavailable.
4. Do Not Sign Anything or Give Any Statements
If you are contacted by anyone representing Johnson & Johnson, its insurers, or any claims-resolution program, do not sign anything and do not give any recorded statement. A fast settlement check that arrives with a release attached, before you have spoken to a lawyer, is designed to close your case for a fraction of its value.
5. Confirm Your Deadline
The statute of limitations that applies to your claim depends on your state, your diagnosis date, and the specific legal theory of your case. Most states apply a discovery rule that measures the limitations period from the date of diagnosis — but the length of that period varies, and some states impose an outer deadline (a statute of repose) that can cut off a claim even before discovery. In Texas, where our firm is based, the general personal-injury statute of limitations is two years. Other states range from one to six years. The only way to know your deadline is to have it confirmed for your specific situation. Do not wait to find out.
6. Call Us
The consultation is free. The call costs nothing. We will listen to what happened to you, answer your questions, and tell you honestly whether we believe you have a case and what the next steps would be. If we are not the right fit for your situation, we will tell you. If we take your case, you do not pay us anything unless we win.
Call 1-888-ATTY-911 (1-888-288-9911). We answer 24 hours a day, seven days a week — not with an answering service, but with live staff. Ralph Manginello has spent 27+ years in courtrooms, including federal court, and was a journalist before he was a lawyer — he knows how to find the story the documents tell and how to put it in front of a jury. Lupe Peña spent years inside a national insurance-defense firm — the rooms where claims like yours are priced and devalued — and now sits on your side of the table. Lupe is fluent in Spanish and conducts full consultations in Spanish without an interpreter. Hablamos Español.
Frequently Asked Questions
I used talcum powder for years and was just diagnosed with mesothelioma. Is it too late to file a lawsuit?
In most states, the statute of limitations for toxic exposure claims does not start running at the time you were exposed to the product. It starts at the time you discovered — or reasonably should have discovered — your injury and its connection to the exposure. For mesothelioma, that usually means the clock starts at the date of diagnosis. However, the length of the limitations period varies by state (typically one to six years), and some states have a statute of repose that creates an outer deadline. The only way to know whether you are still within the deadline is to have a lawyer confirm it for your state and your specific situation. Do not assume you are too late — and do not assume you have plenty of time.
The powder I used was Johnson’s Baby Powder. Does that contain asbestos?
The Hopkins testimony indicates that a former J&J toxicologist found chrysotile asbestos in the company’s talc and documented it with photographs. Johnson & Johnson has historically maintained that its talc products do not contain asbestos. The litigation addresses this dispute directly. If you used J&J talc products and were subsequently diagnosed with mesothelioma or ovarian cancer, the specific question of whether the particular product you used contained asbestos is a matter for mineralogical testing and expert analysis — which is why preserving any remaining product containers matters.
I have ovarian cancer, not mesothelioma. Can I still have a talc case?
Yes. The trial where the Hopkins testimony was presented involves three women with ovarian cancer, not mesothelioma. The causal theory for ovarian cancer is that talc particles applied to the perineal area can migrate to the ovaries, where asbestos-contaminated fibers and chronic inflammation may contribute to malignant transformation. The concealment evidence — J&J’s internal knowledge of asbestos in its talc and its failure to disclose that to the FDA — applies to ovarian cancer cases just as it applies to mesothelioma cases. The failure to warn is the same regardless of which disease followed.
What if my loved one has already passed away from mesothelioma or ovarian cancer?
You may still have a claim. Wrongful death and survival actions allow certain family members or the estate to pursue a case on behalf of a person who has died. The specific family members who can bring a wrongful death claim, and the damages that are available, vary by state. If your loved one’s deposition was never taken, their product use history can still be established through family member testimony, photographs, receipts, and other documentary evidence. But the deadline for filing a wrongful death claim is often shorter than for a personal injury claim, so confirming the deadline immediately is critical.
Johnson & Johnson filed for bankruptcy. Does that mean I can’t sue them?
No. Johnson & Johnson attempted to use bankruptcy to wall off talc liability three separate times through entities it created (LTL Management LLC and then Red River Talc LLC). All three bankruptcy attempts were dismissed by the courts — the most recent dismissal came on March 31, 2025, from the U.S. Bankruptcy Court for the Southern District of Texas. After the third failure, J&J announced a return to defending cases in the regular tort system. Your right to file a lawsuit and pursue a jury verdict remains intact.
How long does a talc lawsuit take?
The timeline varies depending on whether your case is part of the consolidated MDL proceedings, whether it is filed in state or federal court, the jurisdiction’s trial calendar, and the complexity of your individual case. Some cases resolve through settlement; others go to trial. For mesothelioma patients, whose life expectancy is limited, courts often have procedures to expedite scheduling — but this requires a lawyer to request it. The Hopkins deposition and the internal corporate documents that are already in the litigation record can shorten the discovery timeline because the core liability evidence does not need to be re-developed from scratch for each case.
How much does it cost to hire a lawyer for a talc case?
We handle these cases on a contingency fee basis. That means you do not pay us anything unless we win your case. Our fee is 33.33% if the case resolves before trial and 40% if it goes to trial. The initial consultation is free. We do not get paid unless we recover money for you. You can reach us at our contact page or by calling 1-888-ATTY-911.
I’m not sure I can prove I used Johnson & Johnson talc specifically. Can I still have a case?
Product identification is a critical element of a talc case, but it does not always require a receipt or a product container. Many cases are built on a combination of the plaintiff’s own testimony, family member corroboration, longstanding household habits, and the market dominance of J&J’s talc products during the relevant period. The strength of your product identification evidence is something we evaluate during the initial consultation. If you have a clear memory of using J&J talc products daily or regularly for years, and family members who can corroborate that use, you may have a viable case even without receipts.
What if I used talc products from other brands too?
Multiple talc products may have contained asbestos, and multiple manufacturers may be defendants in the talc litigation. Your exposure history may implicate more than one manufacturer. During the case evaluation, we work to identify every talc product you used, every manufacturer that could be a defendant, and every potential source of recovery. The goal is not to limit your case to one defendant — it is to identify every entity that may be responsible for the harm.
Will I have to go to trial?
Most personal injury and product liability cases settle before trial. However, the decision to settle or go to trial is yours, not ours. Our job is to build the strongest possible case so that the settlement value reflects the full measure of your losses — or, if the defendant will not offer a fair settlement, to try the case to a jury. The concealment evidence described in the Hopkins testimony is the kind of evidence that changes the calculus for both sides: it makes juries angry, it amplifies punitive exposure, and it creates pressure on the defendant to resolve cases rather than face more public trials.
Why This Firm
We are Attorney911 — The Manginello Law Firm, PLLC. We are based in Houston, Texas, and we take toxic tort and product liability cases across the state and, working with local counsel where required, across the country.
Ralph P. Manginello is our Managing Partner. He has been licensed in Texas since November 6, 1998 — 27+ years of trial practice, including admission to the U.S. District Court for the Southern District of Texas. He was a journalist before he was a lawyer, which means he knows how to find the story inside a stack of corporate documents and how to tell it to a jury in language they understand. He is a member of the Texas Trial Lawyers Association, the Houston Bar Association, and the National Association of Criminal Defense Lawyers, among others. He does not like losing.
Lupe Peña is our Associate Attorney. He has been licensed in Texas since December 6, 2012. Before joining this firm, Lupe spent years inside a national insurance-defense firm — the same kind of firm that Johnson & Johnson would hire to defend against your claim. He sat in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. He knows how claims are priced from the inside, how reserves are set in the first 48 hours, how recorded statements are engineered, and how settlement offers are calibrated to be just enough to tempt and not enough to compensate. Now he uses that knowledge for injured clients. Lupe is fluent in Spanish and conducts full client consultations in Spanish without an interpreter.
We also handle wrongful death claims for families who have lost a loved one to mesothelioma or ovarian cancer tied to talc exposure. Our firm has a dedicated mesothelioma and toxic exposure practice page for the Beaumont and Golden Triangle region, where refinery and chemical plant workers have faced asbestos exposure for decades — the same carcinogen, the same disease pathway, the same corporate indifference that the talc litigation exposes.
What the First Call Feels Like
The call is free. The consultation is free. We will listen to what happened to you. We will ask about your diagnosis, your treatment, your history of talc product use, and your family situation. We will answer your questions honestly — including whether we believe you have a case, what we would do next, and what the timeline might look like. If we take your case, the preservation letter goes out immediately. The records demand follows. The clock starts working for you.
And if we are not the right fit for your situation — if your case belongs with a different firm or in a different jurisdiction — we will tell you that, too, and help point you in the right direction. That is not generosity. That is the job.
Past results depend on the facts of each case and do not guarantee future outcomes.
Call 1-888-ATTY-911 (1-888-288-9911). Free consultation. No fee unless we win your case. 24/7 live staff — not an answering service. Hablamos Español.